REPORT ID 15345

EMEA (Europe, Middle East and Africa) 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2017

Publish Date
29-Nov-17
Pages
105
Format
Electronic (PDF)

In this report, the EMEA 23-Valent Pneumococcal Polysaccharide Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of 23-Valent Pneumococcal Polysaccharide Vaccine for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA 23-Valent Pneumococcal Polysaccharide Vaccine market competition by top manufacturers/players, with 23-Valent Pneumococcal Polysaccharide Vaccine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    MSD
    Sanofipasteur
    CDIBP
    ...

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Single Dose Vial
    Pre-filled Syringe

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of 23-Valent Pneumococcal Polysaccharide Vaccine for each application, including
    For Children (2-10)
    For Person (10-64)
    For The old (?65)

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2017
1 23-Valent Pneumococcal Polysaccharide Vaccine Overview
    1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
    1.2 Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
        1.2.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Single Dose Vial
        1.2.4 Pre-filled Syringe
    1.3 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market by Application/End Users
        1.3.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 For Children (2-10)
        1.3.3 For Person (10-64)
        1.3.4 For The old (?65)
    1.4 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market by Region
        1.4.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of 23-Valent Pneumococcal Polysaccharide Vaccine (2012-2022)
        1.5.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market Competition by Players/Manufacturers
        2.1.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Share by Players (2012-2017)
        2.1.3 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Players (2012-2017)
    2.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine (Volume and Value) by Type/Product Category
        2.2.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2012-2017)
    2.3 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine (Volume) by Application
    2.4 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine (Volume and Value) by Region
        2.4.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Price by Region (2012-2017)

3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Value (2012-2017)
        3.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2012-2017)
    3.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type
    3.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Application
    3.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Countries (2012-2017)
        3.4.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2012-2017)
        3.4.3 Germany 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)
        3.4.4 France 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)
        3.4.5 UK 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)
        3.4.6 Russia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)
        3.4.7 Italy 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)
        3.4.8 Benelux 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)

4 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Value (2012-2017)
        4.1.1 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2012-2017)
    4.2 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type
    4.3 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Application
    4.4 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Countries (2012-2017)
        4.4.2 Middle East 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)
        4.4.4 Israel 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)
        4.4.5 UAE 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)
        4.4.6 Iran 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)

5 Africa 23-Valent Pneumococcal Polysaccharide Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Value (2012-2017)
        5.1.1 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2012-2017)
    5.2 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type
    5.3 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Application
    5.4 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Volume by Countries (2012-2017)
        5.4.2 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Countries (2012-2017)
        5.4.3 South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)
        5.4.5 Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)
        5.4.6 Algeria 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2012-2017)

6 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers/Players Profiles and Sales Data
    6.1 MSD
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofipasteur
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 CDIBP
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    ...

7 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
    7.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2017-2022)
    11.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Price and Trend Forecast (2017-2022)
    11.2 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2017-2022)
    11.7 EMEA 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer